Bronchogen is a synthetic tetrapeptide composed of alanine, glutamic acid, aspartic acid, and leucine (AEDL). It has been investigated as a short peptide bioregulator in experimental models involving respiratory-tissue and bronchial epithelial-cell biology.

Laboratory research involving Bronchogen has examined gene-expression regulation, bronchial epithelial-cell activity, cellular differentiation, proliferative signaling, and peptide-mediated cellular regulation. Experimental studies have used AEDL to investigate how short peptide sequences may influence molecular processes within respiratory epithelial cells.

Bronchogen remains an experimental research compound for studying short-peptide signaling, respiratory epithelial biology, gene regulation, and cellular regulatory mechanisms.